ClassID:

21025

A61K38/45 - page 4 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Transferases (2)

Recent Application in this class:
#901
20150225704
2015-08-13

Neuroprotective peptides that inhibit interaction between palmitoyl acyl transferase zinc-finger DHHC type containing 17 (zD17) and c-jun N-terminal kinase (JNK)

#902
20150224142
2015-08-13

Inhibition of diacylglycerol kinase to augment adoptive T cell transfer

#903
20150218288
2015-08-06

Method for stimulating or enhancing proliferation of cells by activating the mucin 1 (MUC1) receptor

#904
20150216949
2015-08-06

Methods of treating cancer of the central nervous system

#905
20150204874
2015-07-23

Predicting and treating diabetic complications

#906
20150190504
2015-07-09

WOUND HEALING

#907
20150190480
2015-07-09

COMBINATION PRODUCTS FOR TREATING CANCER

#908
20150190479
2015-07-09

DELIVERY OF CHOLESTERYL ESTER TO STEROIDOGENIC TISSUES

#909
20150190432
2015-07-09

Methods and compositions for in vivo induction of pancreatic beta cell formation

#910
20150182600
2015-07-02

METHODS OF TREATING ANEMIA AND RED BLOOD CELL DYSFUNCTION WITH LECITHIN CHOLESTEROL ACYLTRANSFERASE

#911
20150176027
2015-06-25

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#912
20150176026
2015-06-25

Replication competent pseudo-type retrovirus vector system

#913
20150175978
2015-06-25

Composition for preventing or treating rheumatoid arthritis

#914
20150166616
2015-06-18

Modified polynucleotides for the production of cosmetic proteins and peptides

#915
20150164797
2015-06-18

Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells

#916
20150157686
2015-06-11

Treatments of oxidative stress conditions

#917
20150152165
2015-06-04

Matrix metalloproteinase cleavable protein polymers for cancer gene therapy

#918
20150150950
2015-06-04

Methods and products relating to GSK3β regulation

#919
20150147330
2015-05-28

High-affinity monoclonal antibodies to glypican-3 and use thereof

#920
20150139953
2015-05-21

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#921
20150139939
2015-05-21

Cancer stem cell targeted cancer vaccines

#922
20150133389
2015-05-14

Methods of treatment of cancer using SRC-modulating peptides

#923
20150132265
2015-05-14

Methods and Compositions for Treating Disease

#924
20150125538
2015-05-07

Compositions and methods for oxalate reduction

#925
20150125438
2015-05-07

Anti-Inflammatory Peptides and Composition Comprising the Same

#926
20150119475
2015-04-30

Methods of detecting Akt3 and administering Ax1 inhibitor

#927
20150118259
2015-04-30

28 kDa GST proteins from schistosoma for the use thereof in the treatment of inflammatory autoimmune diseases generating a Th1 and/or Th17 response

#928
20150118216
2015-04-30

Delivery of negatively charged proteins using cationic lipids

#929
20150104427
2015-04-16

ENZYME-ASSISTED SPATIAL DECORATION OF BIOMATERIALS

#930
20150098927
2015-04-09

METHODS FOR TREATMENT AND DIAGNOSIS OF CANCER

#931
20150093334
2015-04-02

Vault and vault like carrier molecules

#932
20150086541
2015-03-26

Methods of cytotoxic gene therapy to treat tumors

#933
20150079135
2015-03-19

METHODS FOR TREATING AND MONITORING THE STATUS OF CANCER

#934
20150079117
2015-03-19

Paramyxovirus immunogens and related materials and methods

#935
20150079027
2015-03-19

ANTITUMOR PROTOCOL

#936
20150071906
2015-03-12

Delivery system for functional nucleases

#937
20150071903
2015-03-12

Use of cationic lipids to deliver CAS9

#938
20150065535
2015-03-05

Method of restoring the incretin effect

#939
20150065432
2015-03-05

Visfatin therapeutic agents for the treatment of acne and other conditions

#940
20150064236
2015-03-05

Modified polynucleotides for the production of proteins

#941
20150038560
2015-02-05

Methods and compositions for treating neuropathies

#942
20150037874
2015-02-05

Chimeric adenoviruses for use in cancer treatment

#943
20150030580
2015-01-29

PEGylated fibrinogen precursor molecule

#944
20150030574
2015-01-29

Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof

#945
20150023987
2015-01-22

Immunogenic compositions and reagents for preparing

#946
20150023949
2015-01-22

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER

#947
20150017255
2015-01-15

Methods for treating cardiac conditions

#948
20150017126
2015-01-15

Poxviral oncolytic vectors

#949
20150010575
2015-01-08

Combination therapy for the treatment of cancer using an anti-C-met antibody

#950
20150004217
2015-01-01

mRNA for use in treatment of human genetic diseases

#951
20150004101
2015-01-01

Treatment of ocular neovascularization using anti-VEGF proteins

#952
20150004099
2015-01-01

Targeting of chondroitin sulfate glycans

#953
20140363416
2014-12-11

Methods and compositions for reducing blood glucose

#954
20140341876
2014-11-20

METHOD FOR THE TREATMENT OF PULMONARY DISEASE AND METHOD OF PRODUCING PROTEINS OF USE THEREIN

#955
20140336562
2014-11-13

Presbyopia treatment by lens alteration

#956
20140328927
2014-11-06

Anti-cancer nanoparticle compositions and methods of use

#957
20140328822
2014-11-06

Method for preparing highly concentrated fibrinogen solution and method for preparing fibrin sealant by using thereof

#958
20140328801
2014-11-06

Accumulation of metabolic products in bacterial microcompartments

#959
20140314735
2014-10-23

PROCESS FOR CONCENTRATION OF A POLYPEPTIDE

#960
20140302002
2014-10-09

Use of GSTP1

#961
20140294799
2014-10-02

USE OF COMPOSITIONS HAVING A LOW POLYAMINE CONTENT IN THE PREVENTION OR TREATMENT OF ADVERSE EFFECTS LINKED TO CANCER TREATMENT

#962
20140294798
2014-10-02

RbAp48 transgenic mice for drug discovery in age-related memory decline

#963
20140288160
2014-09-25

Cleavable lipids

#964
20140286929
2014-09-25

Proteomic IPF markers

#965
20140286928
2014-09-25

Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)

#966
20140286927
2014-09-25

METHOD FOR THE TREATMENT OF ULCERATIVE COLITIS IN PATIENTS REFRACTORY TO STEROID THERAPY USING LEACHED LIGAND FIBRIN STABILIZING COMPOSITION

#967
20140255380
2014-09-11

Methods of administering 3,4-diaminopyridine

#968
20140249208
2014-09-04

Modified polynucleotides for treating protein deficiency

#969
20140242155
2014-08-28

Compounds, compositions, methods, and kits relating to telomere extension

#970
20140242058
2014-08-28

ST6GAL I MEDIATED MODULATION OF HEMATOPOIESIS

#971
20140234318
2014-08-21

TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF

#972
20140227243
2014-08-14

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS

#973
20140221465
2014-08-07

Modified polynucleotides for treating galactosylceramidase protein deficiency

#974
20140219980
2014-08-07

Treatment for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

#975
20140219965
2014-08-07

Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance

#976
20140200262
2014-07-17

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

#977
20140199371
2014-07-17

Modified polynucleotides encoding basic helix-loop-helix family member E41

#978
20140199285
2014-07-17

PURINE NUCLEOSIDE PHOSPHORYLASE AS ENZYMATIC ACTIVATOR OF NUCLEOSIDE PRODRUGS

#979
20140193425
2014-07-10

TREATMENT OF CANCER WITH ALK1 ANTAGONISTS

#980
20140186432
2014-07-03

Modified polynucleotides encoding citeD4

#981
20140186325
2014-07-03

Methods of Cancer Treatment and Prevention Through the Modulation of SIRT4 Activity

#982
20140179771
2014-06-26

MODIFIED POLYNUCLEOTIDES FOR TREATING DOLICHYL-PHOSPHATE (UDP-N-ACETYLGLUCOSAMINE) N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE 1 (GLCNAC-1-P TRANSFERASE) PROTEIN DEFICIENCY

#983
20140179613
2014-06-26

COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF

#984
20140178353
2014-06-26

Bacterial anti-phage defense systems

#985
20140178352
2014-06-26

Peptide inhibitors of protein kinase C

#986
20140178351
2014-06-26

Compositions and methods relating to argininosucccinate synthetase

#987
20140170119
2014-06-19

Multi-chamber applicator for gelatin solution

#988
20140161873
2014-06-12

Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator

#989
20140154231
2014-06-05

Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins

#990
20140148580
2014-05-29

Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins

#991
20140147432
2014-05-29

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

#992
20140141067
2014-05-22

Modified polynucleotides encoding septin-4

#993
20140127182
2014-05-08

Using GNMT as a Novel Therapeutic or Preventing Agent for Fatty Liver Related Diseases

#994
20140113960
2014-04-24

Modified polynucleotides encoding granulysin

#995
20140113836
2014-04-24

Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid

#996
20140107189
2014-04-17

Modified polynucleotides encoding apoptosis inducing factor 1

#997
20140105966
2014-04-17

Modified polynucleotides encoding hepatitis A virus cellular receptor 2

#998
20140105965
2014-04-17

Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1

#999
20140105964
2014-04-17

Modified polynucleotides encoding aquaporin-5

#1000
20140105923
2014-04-17

Tumor antigen proteins or genes of polo-like kinase 1

#1001
20140100265
2014-04-10

Gene delivery vehicles in the treatment of neurodegenerative diseases

#1002
20140093490
2014-04-03

Method for screening a glutamate release inhibitor in an astrocyte

#1003
20140093486
2014-04-03

METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELLS AND ITS APPLICATIONS

#1004
20140079772
2014-03-20

Compositions and methods for the treatment of cancer

#1005
20140079681
2014-03-20

Prodrug anti-cancer therapy

#1006
20140079680
2014-03-20

Melatonin-based treatment and diagnosis of bile duct disease

#1007
20140037660
2014-02-06

Complexes of RNA and cationic peptides for transfection and for immunostimulation

#1008
20140030324
2014-01-30

Compositions and methods for treating or preventing oxalate-related disease

#1009
20140030245
2014-01-30

Compositions and methods for treating cancer

#1010
20140030244
2014-01-30

EXTRACTS ISOLATED FROM ELECTROPORATED AMBHIBIAN OOCYTES AND USE THEREOF IN TREATING DISEASES AND DISORDERS

#1011
20140023631
2014-01-23

METHODS OF TREATING ANEMIA AND RED BLOOD CELL DYSFUNCTION WITH LECITHIN CHOLESTEROL ACYLTRANSFERASE

#1012
20140010800
2014-01-09

Detection of mutations in a gene associated with resistance to viral infection, OAS1

#1013
20140005102
2014-01-02

Oligoadenylate synthetase (OAS)

#1014
20140005101
2014-01-02

Oligoadenylate synthetase (OAS)

#1015
20130345114
2013-12-26

Agent for treating allergic or hypersensitivity condition

#1016
20130336953
2013-12-19

USE OF CREATINE KINASE FOR PREVENTING OR TREATING ADDICTION TO OPIATES

#1017
20130336952
2013-12-19

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS

#1018
20130330315
2013-12-12

Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug

#1019
20130309249
2013-11-21

MATERIALS AND METHODS FOR THE PROPHYLACTIC TREATMENT OF A PRE-MALIGNANT CONDITION

#1020
20130295075
2013-11-07

COMPOSITIONS AND METHODS OF TREATING GLAUCOMA

#1021
20130288983
2013-10-31

Variant activin receptor polypeptides and uses thereof

#1022
20130288959
2013-10-31

Screening method for antidiabetic agent using newly identified insulin secretion regulation factor

#1023
20130287737
2013-10-31

Poxviral oncolytic vectors

#1024
20130281517
2013-10-24

Cyclopropanecarboxylate esters of purine analogues

#1025
20130281451
2013-10-24

Indolin-2-one derivatives as protein kinase inhibitors

#1026
20130273057
2013-10-17

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF VASCULAR INFLAMMATORY DISORDERS OR ENDOTHELIAL CELL DISORDERS

#1027
20130259924
2013-10-03

Modified polynucleotides for the production of biologics and proteins associated with human disease

#1028
20130259923
2013-10-03

Modified polynucleotides for the production of secreted proteins

#1029
20130251821
2013-09-26

VEGF-activated trail ligands

#1030
20130243743
2013-09-19

METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS

#1031
20130236441
2013-09-12

METHODS OF TREATING AND PREVENTING THROMBOTIC DISEASES USING ASK1 INHIBITORS

#1032
20130230902
2013-09-05

Chimeric adenoviruses for use in cancer treatment

#1033
20130224223
2013-08-29

Compositions and Methods for Treating Neurological Disorders

#1034
20130224176
2013-08-29

Method of restoring the incretin effect

#1035
20130217752
2013-08-22

Method of deriving mature hepatocytes from human embryonic stem cells

#1036
20130217095
2013-08-22

Chimeric adenoviruses for use in cancer treatment

#1037
20130210734
2013-08-15

METHOD OF PREVENTING PROGRESSION OF HYPERTENSION-INDUCED HEART FAILURE WITH PKC PEPTIDES

#1038
20130209409
2013-08-15

Chimeric adenoviruses for use in cancer treatment

#1039
20130203088
2013-08-08

Methods and means for diagnosing spondylarthritis using autoantibody markers

#1040
20130202594
2013-08-08

ALK1 Antagonists and Their Uses in Treating Renal Cell Carcinoma

#1041
20130202553
2013-08-08

Mobilization of hematopoietic stem cells

#1042
20130195770
2013-08-01

COMPOSITION AND METHOD FOR REDUCING ATHEROSCLEROTIC LESIONS

#1043
20130177547
2013-07-11

ANCESTRAL SERINE PROTEASE COAGULATION CASCADE EXERTS A NOVEL FUNCTION IN EARLY IMMUNE DEFENSE

#1044
20130156795
2013-06-20

METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF

#1045
20130156776
2013-06-20

Compositions and methods for treating cancer and modulating stress granule formation

#1046
20130156764
2013-06-20

NEUTRALIZATION OF FLT3 LIGAND AS A LEUKEMIA THERAPY

#1047
20130150294
2013-06-13

Na+/K+-ATPase-specific peptide inhibitors/activators of Src and Src family kinases

#1048
20130144260
2013-06-06

Device and method for the controlled delivery of ophthalmic solutions

#1049
20130136729
2013-05-30

COMPOSITIONS AND METHODS FOR TARGETING AND TREATING DISEASES AND INJURIES USING ADENO-ASSOCIATED VIRUS VECTORS

#1050
20130129702
2013-05-23

Materials and methods for prevention and treatment of RNA viral diseases

#1051
20130116267
2013-05-09

Role of PI3K P110 Delta Signaling in Retroviral Infection and Replication

#1052
20130108644
2013-05-02

Inhibition of AXL signaling in anti-metastatic therapy

#1053
20130101510
2013-04-25

Methods of treating Parkinson's disease using viral vectors

#1054
20130084275
2013-04-04

Methods and compositions for reducing interleukin-4 or interleukin-13 signaling

#1055
20130065299
2013-03-14

ACTRIIB-FC polynucleotides, polypeptides, and compositions

#1056
20130059769
2013-03-07

TOPICALLY ADMINISTERED, SKIN-PENETRATING GLYCOSAMINOGLYCAN FORMULATIONS SUITABLE FOR USE IN COSMETIC AND PHARMACEUTICAL APPLICATIONS

#1057
20130052178
2013-02-28

CHOLESTEROL ESTER FOR REDUCING CHOLESTEROL ABSORPTION

#1058
20130052177
2013-02-28

Monomeric forms of human aminoacyl-t-RNA synthetases having non-canonical biological activities

#1059
20130045194
2013-02-21

Delivery of Cholesteryl Ester to Steroidogenic Tissues

#1060
20130040310
2013-02-14

ULK1 COMPOSITIONS, INHIBITORS, SCREENING AND METHODS OF USE

#1061
20130039891
2013-02-14

POXVIRAL ONCOLYTIC VECTORS

#1062
20130028885
2013-01-31

Methods to predict and prevent resistance to taxoid compounds

#1063
20130012447
2013-01-10

PROTEIN KINASE C-DELTA INHIBITORS THAT PROTECT AGAINST CELLULAR INJURY AND INFLAMMATION AND PROMOTE ASTROCYTE PROLIFERATION

#1064
20120328609
2012-12-27

Modulation of Axon Degeneration

#1065
20120328595
2012-12-27

Variant activin receptor polypeptides and uses thereof

#1066
20120328526
2012-12-27

Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof

#1067
20120321608
2012-12-20

DETECTION OF MUTATIONS IN A GENE ASSOCIATED WITH RESISTANCE TO VIRAL INFECTION, OAS1

#1068
20120282237
2012-11-08

USE OF PROTEIN ARGININE METHYLTRANSFERASES IN REGULATING HEMATOPOIETIC DIFFERENTIATION

#1069
20120276074
2012-11-01

Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption

#1070
20120270810
2012-10-25

Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices

#1071
20120258908
2012-10-11

Pharmaceutical compositions for the treatment of virus infection

#1072
20120253027
2012-10-04

Detection of mutations in a gene associated with resistance to viral infection, OAS1

#1073
20120231524
2012-09-13

Chimeric adenoviruses for use in cancer treatment

#1074
20120213809
2012-08-23

Vault complexes for cytokine delivery

#1075
20120213761
2012-08-23

Use of GSTP1

#1076
20120201824
2012-08-09

Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance Immunogenicity

#1077
20120195864
2012-08-02

CELLS GENETICALLY MODIFIED TO COMPRISE PANCREATIC ISLET GLUCOKINASE AND USES THEREOF

#1078
20120184519
2012-07-19

Compositions and Methods for Preventing or Treating Influenza Virus Infection

#1079
20120183540
2012-07-19

Methods of promoting fat loss comprising administering an ALK7 inhibitor

#1080
20120177724
2012-07-12

Lipid vesicle compositions and methods of use

#1081
20120177627
2012-07-12

Upregulation of integrin linked kinase (ILK) to provide cardioprotective effects

#1082
20120171220
2012-07-05

Further use of protein kinase N beta

#1083
20120164172
2012-06-28

Cancer therapy

#1084
20120164123
2012-06-28

Method for the treatment of pulmonary disease and method of producing proteins of use therein

#1085
20120156246
2012-06-21

REPROGRAMMING CANCER CELLS

#1086
20120142756
2012-06-07

mRNA for use in treatment of human genetic diseases

#1087
20120134969
2012-05-31

PHARMACEUTICAL COMPOSITION CONTAINING NUCLEAR FACTOR INVOLVED IN PROLIFERATION AND DIFFERENTIATION OF CENTRAL NEURONAL CELLS

#1088
20120129790
2012-05-24

Methods of use of epsilon inhibitor compounds for the attenuation of pain

#1089
20120121571
2012-05-17

Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus

#1090
20120107298
2012-05-03

Methods of treating anemia and red blood cell dysfunction with lecithin cholesterol acyltransferase

#1091
20120107282
2012-05-03

NEURAL STEM CELL COMPOSITION CAPABLE OF TREATING CANCER AND METHOD OF TREATMENT

#1092
20120093797
2012-04-19

COMBINED USE OF CREATINE PHOSPHATE AND CREATINE PHOSPHOKINASE FOR TREATMENT OF ARTERIOSCLEROSIS

#1093
20120087980
2012-04-12

STIMULATION OF NEUROREGENERATION BY FLAVONOID GLYCOSIDES

#1094
20120082677
2012-04-05

COMPOSITIONS FOR THE TREATMENT OF HCV AND HBV

#1095
20120076767
2012-03-29

Process for concentration of a polypeptide

#1096
20120076764
2012-03-29

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS

#1097
20120058120
2012-03-08

Targets for Growth Factor Signalling and Methods of Therapy

#1098
20120045452
2012-02-23

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

#1099
20120045451
2012-02-23

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

#1100
20120039905
2012-02-16

The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection

#1101
20120039881
2012-02-16

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS

#1102
20120034167
2012-02-09

Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer

#1103
20120027745
2012-02-02

ALANINE-GLYOXYLATE AMINOTRANSFERASE THERAPEUTICS

#1104
20120027742
2012-02-02

Methods for treating adult respiratory distress syndrome

#1105
20120027727
2012-02-02

TARGETED NANOPARTICLES FOR CANCER AND OTHER DISORDERS

#1106
20120022013
2012-01-26

METHODS AND COMPOSITIONS FOR EXTENDING THE LIFE SPAN AND INCREASING THE STRESS RESISTANCE OF CELLS AND ORGANISMS

#1107
20120020911
2012-01-26

Pegylated fibrinogen precursor molecule

#1108
20120015820
2012-01-19

METHODS AND COMPOSITIONS FOR POLYPEPTIDE ENGINEERING

#1109
20120003227
2012-01-05

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF VASCULAR INFLAMMATORY DISORDERS OR ENDOTHELIAL CELL DISORDERS

#1110
20110318326
2011-12-29

Compositions and methods for causing neurite outgrowth

#1111
20110318325
2011-12-29

Inositol Pyrophosphates Determine Exocytotic Capacity

#1112
20110311506
2011-12-22

PIGGYBAC TRANSPOSON VARIANTS AND METHODS OF USE

#1113
20110300109
2011-12-08

Compositions and methods for treating cancer

#1114
20110287041
2011-11-24

Aldehyde tags, uses thereof in site-specific protein modification

#1115
20110286984
2011-11-24

Recombinant vectors and hosts comprising human glucokinase encoding gene

#1116
20110275575
2011-11-10

Peptide inhibitors of protein kinase C

#1117
20110257082
2011-10-20

HIV-1 integrase derived stimulatory peptides interfering with integrase—Rev protein binding

#1118
20110257021
2011-10-20

USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER

#1119
20110250704
2011-10-13

Aldehyde tags, uses thereof in site-specific protein modification

#1120
20110250251
2011-10-13

Cosmetic Methods And Compositions For Repairing Human Skin

#1121
20110250179
2011-10-13

METHODS FOR TREATMENT AND DIAGNOSIS OF CANCER

#1122
20110243913
2011-10-06

Biomaterial Compositions and Methods of Use

#1123
20110237501
2011-09-29

Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1

#1124
20110236495
2011-09-29

Anti-cancer nanoparticle compositions and methods of use

#1125
20110217693
2011-09-08

Generation of replication competent viruses for therapeutic use

#1126
20110217280
2011-09-08

METHODS FOR TREATING NEUROPSYCHIATRIC CONDITIONS

#1127
20110212108
2011-09-01

NEUREGULIN/ERBB SIGNALING AND INTEGRIN

#1128
20110212073
2011-09-01

Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs

#1129
20110207694
2011-08-25

MAMMALIAN HYPOTHALAMIC NUTRIENT MODULATION OF GLUCOSE METABOLISM

#1130
20110206652
2011-08-25

Methods for treating atherosclerosis

#1131
20110191871
2011-08-04

METHODS TO IDENTIFY FACTORS ASSOCIATED WITH MUSCLE GROWTH AND USES THEREOF

#1132
20110189166
2011-08-04

METHODS OF TREATING HEMORHEOLOGIC ABNORMALITIES IN MAMMALS

#1133
20110189155
2011-08-04

Large Form Of Human 2',5'-Oligoadenylate Synthetase OAS3 for Preventing or Treating Infection With Positive-Sense Single-Stranded RNA Viruses

#1134
20110171219
2011-07-14

TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS

#1135
20110171196
2011-07-14

METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN

#1136
20110150887
2011-06-23

Methods and products relating to GSK3β regulation

#1137
20110150855
2011-06-23

Enzyme Composition and Use Thereof

#1138
20110144034
2011-06-16

INHIBITION OF TUMOR METASTASES USING PROTEIN KINASE C (PKC) INHIBITORS

#1139
20110142811
2011-06-16

MEASLES VIRUS FOR THE ELIMINATION OF UNWANTED CELL POPULATIONS

#1140
20110135692
2011-06-09

Anti-tumor immunotherapy

#1141
20110135655
2011-06-09

Role of PI3K p110 delta Signaling in Retroviral Infection and Replication

#1142
20110135622
2011-06-09

Presbyopia treatment by lens alteration of disulfide bonds and reduction

#1143
20110123510
2011-05-26

Methods of Affecting Biological Function Through Circadian Clock Feedback Cycle by NAMPT-Mediated NAD+ Biosynthesis

#1144
20110118293
2011-05-19

Method of restoring the incretin effect

#1145
20110117185
2011-05-19

Methods for treating or preventing heart damage with integrin-linked kinase (ILK) compositions

#1146
20110117072
2011-05-19

Polypeptide variants of sleeping beauty transposase

#1147
20110104138
2011-05-05

USE OF THE INNATE IMMUNITY GENE OASL FOR PREVENTING OR TREATING INFECTION WITH NEGATIVE STRAND RNA VIRUSES

#1148
20110097329
2011-04-28

COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION

#1149
20110092577
2011-04-21

Inositol Pyrophosphates Determine Exocytotic Capacity

#1150
20110091584
2011-04-21

Lymphatic vessel stabilizer

#1151
20110088457
2011-04-21

Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid

#1152
20110086002
2011-04-14

Restoration of hearing loss

#1153
20110082085
2011-04-07

PEPTIDES DERIVED FROM THE C2 DOMAIN OF EPSILON PKC AND METHODS OF USE, THEREOF

#1154
20110081370
2011-04-07

Methods and compositions for modulating immune tolerance

#1155
20110081359
2011-04-07

Alpha 5 beta 1 and its ability to regulate the cell survival pathway

#1156
20110071073
2011-03-24

Detection of mutations in a gene associated with resistance to viral infection, OAS1

#1157
20110070218
2011-03-24

Methods of treating cancer of the central nervous system

#1158
20110060120
2011-03-10

IMMUNOGENIC TREATMENT OF CANCER BY PEPTIDES INDUCING THE PLASMA MEMBRANE EXPOSURE OF ERP57

#1159
20110059479
2011-03-10

MODULATION OF THE INTEGRIN LINKED KINASE SIGNALING PATHWAY TO PROMOTE CARDIAC CELL PROLIFERATION AND SELF-RENEWAL

#1160
20110059172
2011-03-10

THERAPEUTIC COMPOSITIONS

#1161
20110059049
2011-03-10

Poxviral oncolytic vectors

#1162
20110053781
2011-03-03

METHODS AND COMPOSITIONS FOR POLYPEPTIDE ENGINEERING

#1163
20110052711
2011-03-03

Controlled release multidrug formulations for spinal cord injury

#1164
20110052603
2011-03-03

METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME

#1165
20110052558
2011-03-03

Materials and methods for prevention and treatment of RNA viral diseases

#1166
20110045568
2011-02-24

METHOD FOR RESTORING BMP-RECEPTOR SIGNALING IN A CELL

#1167
20110044948
2011-02-24

Poxviral oncolytic vectors

#1168
20110039916
2011-02-17

Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof

#1169
20110034501
2011-02-10

Method of restoring the incretin effect

#1170
20110028536
2011-02-03

METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION

#1171
20110021422
2011-01-27

Method and compositions for prevention and treatment of diabetic and aged skin

#1172
20110020344
2011-01-27

Human monoclonal antibodies specific for CD22

#1173
20110020274
2011-01-27

Mobilization of hematopoietic stem cells

#1174
20110014165
2011-01-20

Thymidylate Kinase Mutants and Uses Thereof

#1175
20110008418
2011-01-13

Compositions and methods for the treatment of cancer

#1176
20110008402
2011-01-13

SOULUBLE B-N-ACETYLGLUCOSEAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF

#1177
20110008320
2011-01-13

Further Use of Protein Kinase N Beta

#1178
20110008313
2011-01-13

tPA mutant in the treatment of acute brain injury and neurodegenerative disorders

#1179
20110002944
2011-01-06

Compositions and Methods to Promote Neural Cell Growth

#1180
20100322974
2010-12-23

Targeting the histone code as a bacterial strategy for selectively modulating gene expression

#1181
20100322925
2010-12-23

ALK7 AND MYOSTATIN INHIBITORS AND USES THEREOF

#1182
20100322914
2010-12-23

Prodrug anti-cancer therapy

#1183
20100316701
2010-12-16

Compositions and method for manipulating PIM-1 activity in circulatory system cells

#1184
20100316607
2010-12-16

Hepatitis C virus inhibitors

#1185
20100311663
2010-12-09

MEMORY INFLUENCING PROTEIN

#1186
20100310543
2010-12-09

METHOD OF PREVENTING AND TREATING ACUTE BRAIN PATHOLOGIES

#1187
20100310542
2010-12-09

Pharmaceutical Compositions for treating wouds and related methods

#1188
20100303839
2010-12-02

Methods and compositions for treatment of cancer using oncolytic RSV activity

#1189
20100297098
2010-11-25

Purification of factor XIII polypeptides from biological materials

#1190
20100297024
2010-11-25

Promoter inducible by reactive oxygen species and vector comprising the same

#1191
20100292309
2010-11-18

INDUCING IMMUNE-MEDIATED TUMOR CELL DEATH

#1192
20100286050
2010-11-11

Method of preventing progression of hypertension-induced heart failure with PKC peptides

#1193
20100285033
2010-11-11

Compositions and methods for CaMKII inhibitors and uses thereof

#1194
20100278736
2010-11-04

Methods of screening for neoplastic disease states

#1195
20100272702
2010-10-28

Methods and compositions for treating neuropathies

#1196
20100267133
2010-10-21

Actriib-Fc polynucleotides, polypeptides, and compositions

#1197
20100260680
2010-10-14

NOVEL BONE MASS INCREASING AGENT

#1198
20100256348
2010-10-07

Oligoadenylate synthetase (OAS)

#1199
20100226908
2010-09-09

Compositions for promoting wound healing and treating psoriasis

#1200
20100226856
2010-09-09

Dynamic bio-nanoparticle elements